(A, lower) An IP was obtained using anti-RyR antibody and then immunoblotted with anti-GSH antibody.B.Quantitative analysis of GSH by scanning densitometry. in Ca2+signaling and the activities of SERCA and RyR. All these abnormalities were significantly ameliorated by treatment with ARI or SDI. We showed that this polyol pathway activities increase the level of peroxynitrite, which enhances the tyrosine nitration of SERCA and irreversibly change it to form SERCAC674-SO3H. This leads to reduced level of S-glutathiolated SERCA, contributing to its inactivation. The polyol pathway activities also deplete the level of GSH, leading to decreased active RyR, the S-glutathiolated RyR. Thus, in I/R heart, inhibition of polyol pathway improved the function of SERCA and RyR by protecting them from irreversible oxidation. == INTRODUCTION == Contractile dysfunction often occurs after acute myocardial infarction, cardiac bypass surgery, heart transplantation, and coronary angioplasty (1). It has been shown Ufenamate that early reperfusion after coronary occlusion improves heart functions and reduces infarct size (2). However, reperfusion after a certain time period of ischemia may exacerbate cardiac contractile dysfunction, ultrastructural damage, and changes in myocardial metabolism (3). During ischemia-reperfusion (I/R), cardiac contractile dysfunction is usually attributed to the impairment of calcium (Ca2+) handling activities of the cardiomyocyte. Under normal condition, Ca2+homeostasis is usually exquisitely controlled by regulatory proteins in sarcolemmal and sarcoplasmic reticulum (SR) membranes. Ca2+enters the cardiomyocyte via the L-type Ca2+channels when the sarcolemmal membrane is usually depolarized. Entry of Ca2+triggers further release of Ca2+through the ryanodine Ufenamate receptor (RyR) of the SR, leading to a large increase in cytosolic Ca2+concentration, known as the intracellular [Ca2+] transient ([Ca2+]i) (4). The elevated [Ca2+]i, which stimulates contraction Ufenamate of the myofilaments, is usually removed mainly to the SR by the Ca2+-ATPase (SERCA) and out of the cell by the Na+/Ca2+exchanger (NCX) to initiate relaxation. These periodic changes in [Ca2+] between cytosol and SR control the cycles of excitation-contraction (EC) coupling and relaxation. Abnormalities in Ca2+handling leading to cytosolic [Ca2+] overload, has been suggested to explain contractile dysfunction of the heart following I/R in the heart (3). However, the mechanism is not entirely clear. Apart from the impairment in Ca2+homeostasis, the increase in reactive oxygen species (ROS) within the first few minutes of reperfusion has been proposed to explain the I/R-induced contractile changes in the heart (5). In fact, exposure of the heart to different species of ROS has been shown to cause functional alterations (6) comparable to that observed in the I/R heart. More importantly, these changes have been demonstrated to be attributed to abnormalities in Ca2+handling by the SR (7) and sarcolemma (8). Therefore it Ufenamate is likely that, during I/R, release of ROS impaired the Ca2+handling activities in the cardiomyocytes. In this report we exhibited that polyol pathway contributes to the increased ROS during I/R leading to impairment of two key calcium handling proteins, SERCA and RyR, in the rat heart. Polyol pathway has been implicated in the pathogenesis of various diabetic complications (9,10). In this metabolic pathway, Goat polyclonal to IgG (H+L)(HRPO) glucose is usually reduced to sorbitol by aldose reductase (AR; EC 1.1.1.21) with the oxidation of its co-factor NADPH to NADP, and sorbitol is then converted to fructose by sorbitol dehydrogenase (SDH: EC 1.1.1.14) with the concomitant reduction of NAD+to NADH (11). Under hyperglycemia, increased flux of glucose through the polyol pathway leads to the depletion of NADPH and NAD+. Decrease in the level of NADPH is usually thought to lead to decreased level of reduced glutathione (GSH) because NADPH is also the co-factor for glutathione reductase (GR) that regenerates GSH from oxidized glutathione (GSSG) (12). Further, increased level of NADH, a substrate for NAD(P)H oxidase, would increase ROS. Thus, increased polyol pathway activity would decrease antioxidation defense and increase ROS, resulting in increased oxidative stress. Importantly, it has been demonstrated that this polyol pathway is usually activated in I/R heart even in non-diabetic animals (13). It has been shown to play a key role in I/R induced injury of the heart (1315) and brain (16). The protective effect of inhibition of AR or SDH against myocardial I/R injury is usually thought to be due to normalization of cytosolic NADH/NAD+ratio, thereby preventing the depletion of.